Companies: 10,795·Total market cap: $144.5T
Disc Medicine, Inc.

Disc Medicine, Inc.

IRONNASDAQHealthcare● Active
$65.85
$-1.15(-1.71%)
Market Cap$2.5B
P/E Ratio
52W High$99.5
52W Low$40

Disc Medicine, Inc. (IRON) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · IRON · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

89

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Disc Medicine, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

IRON insider buying and selling by quarter

IRON insider selling · IRON insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.3M644K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · IRON ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

IRON executive sell shares · IRON board member insider trading · IRON insider trading SEC filing

Showing 85 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Savage William Jacob

Chief Medical Officer

Sale

Date

Apr 13

Shares

3,531

Price

$66.12

Value

$233K

View Form 4 on SEC.gov

Savage William Jacob

Chief Medical Officer

Sale

Date

Apr 13

Shares

2,200

Price

$66.81

Value

$147K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Apr 13

Shares

400

Price

$69.00

Value

$28K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Apr 14

Shares

6,257

Price

$69.24

Value

$433K

View Form 4 on SEC.gov

Savage William Jacob

Chief Medical Officer

Sale

Date

Mar 2

Shares

4,392

Price

$65.52

Value

$288K

View Form 4 on SEC.gov

Savage William Jacob

Chief Medical Officer

Sale

Date

Mar 2

Shares

2,986

Price

$66.41

Value

$198K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Feb 25

Shares

353

Price

$69.06

Value

$24K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Feb 17

Shares

4,075

Price

$62.86

Value

$256K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Feb 18

Shares

3,397

Price

$65.01

Value

$221K

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Sale

Date

Feb 18

Shares

3,684

Price

$65.89

Value

$243K

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Sale

Date

Feb 17

Shares

2,853

Price

$62.86

Value

$179K

View Form 4 on SEC.gov

Stephenson Pamela

Chief Commercial Officer

Sale

Date

Feb 17

Shares

5,531

Price

$62.86

Value

$348K

View Form 4 on SEC.gov

Savage William Jacob

Chief Medical Officer

Sale

Date

Feb 17

Shares

3,256

Price

$62.86

Value

$205K

View Form 4 on SEC.gov

Yu Jonathan Yen-Wen

COO

Sale

Date

Feb 17

Shares

3,231

Price

$62.86

Value

$203K

View Form 4 on SEC.gov

Quisel John D

CEO · Director

Sale

Date

Feb 17

Shares

13,264

Price

$62.86

Value

$834K

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Award

Date

Feb 10

Shares

17,000

Price

Value

View Form 4 on SEC.gov

Stephenson Pamela

Chief Commercial Officer

Award

Date

Feb 10

Shares

17,000

Price

Value

View Form 4 on SEC.gov

Savage William Jacob

Chief Medical Officer

Award

Date

Feb 10

Shares

17,000

Price

Value

View Form 4 on SEC.gov

Yu Jonathan Yen-Wen

COO

Award

Date

Feb 10

Shares

17,000

Price

Value

View Form 4 on SEC.gov

Franchi Jean M.

CFO

Award

Date

Feb 10

Shares

19,000

Price

Value

View Form 4 on SEC.gov

Quisel John D

CEO · Director

Award

Date

Feb 10

Shares

55,200

Price

Value

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Option

Date

Jan 20

Shares

1,000

Price

$13.50

Value

$14K

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Sale

Date

Jan 20

Shares

1,000

Price

$69.74

Value

$70K

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Option

Date

Jan 2

Shares

6,500

Price

$13.50

Value

$88K

View Form 4 on SEC.gov

Khara Rahul

Chief Legal Officer

Sale

Date

Jan 2

Shares

350

Price

$77.67

Value

$27K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About IRON insider trading

IRON insider trades

Disc Medicine, Inc. (IRON) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Bitterman Kevin (Director), Savage William Jacob (Chief Medical Officer), Khara Rahul (Chief Legal Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. IRON insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Disc Medicine, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

IRON insider trading · 5 questions

The insiders of Disc Medicine, Inc. (IRON) include executives and directors such as Bitterman Kevin (Director), Savage William Jacob (Chief Medical Officer), Khara Rahul (Chief Legal Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

IRON board member insider tradingwho are IRON insidersIRON insider rosterDisc Medicine, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026